FDA Clearance Tracker · P000053-S105
AMS 800 Artificial Urinary Sphincter with and without InhibiZone Treatment
Last checked: Nov 20, 2026Latest source record: Dec 30, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Dec 30, 2019
Approved
Time to decision
220 days
Received May 24, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P000053-S105
- Device name
- AMS 800 Artificial Urinary Sphincter with and without InhibiZone Treatment
- Applicant
- Boston Scientific Corp
- Applicant location
- Marlboro, MA
- Received
- May 24, 2019
- Decided
- Dec 30, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P000053
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5280
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
Approval for a Liquid Injection Molding process change and silicone material change.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.